共 50 条
- [1] Combination therapy in high-risk non-muscle invasive bladder cancer (HR-NMIBC) with and without BCG prior treatment UROLOGIE, 2023, 62 (03): : 338 - 339
- [4] [18F]-FDG PET/CT FOR BLADDER CANCER STAGING AND DECISION-MAKING IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC) JOURNAL OF UROLOGY, 2022, 207 (05): : E1010 - E1010
- [6] Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR) CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 35 - 48
- [8] HIGH-RISK NMIBC (NON-MUSCLE INVASIVE BLADDER CANCER): PROGNOSTIC VALUE OF CIRCULATING TUMOR CELLS JOURNAL OF UROLOGY, 2011, 185 (04): : E205 - E206
- [9] BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) JOURNAL OF UROLOGY, 2024, 211 (05): : E1169 - E1170